Analyst Consensus ?
ConsensusHold29 ratings
Bullish1551.7%
Neutral1344.8%
Bearish13.5%
Tyson Foods, Inc. · TSN · FY2025 Q2 · Calendar Q2 2025
Tyson maintains FY2025 outlook as chicken and efficiency gains lead
The supplied analysis supports a cautiously constructive operating thesis: resilient protein demand, strong chicken execution, Prepared Foods improvement, and efficiency initiatives provide support, but unchanged guidance and exposure to beef, input costs, tariffs, and execution risks limit confidence in the durability of earnings growth.
Reported Before market openNYSEConsumer Defensive
$19.07B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $0.85
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $13.13B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-7.7%
Event window
SPY move
-0.6%
Same window
Abnormal move
-7.2%
Stock minus SPY
Volume
4.8×
Versus trailing sessions
Subsequent drift
-0.5%
Up to 20 sessions
TSNSPY benchmark
Ask FN2 about TSN FY2025 Q2
Transcript, numbers and history already loaded
What drove TSN's -7.7% move after FY2025 Q2 earnings?What changed in TSN's guidance and outlook in FY2025 Q2?Give me the bull and bear case for TSN after FY2025 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior-quarter analysis, management moved from raised guidance to maintained guidance. The current analysis adds a multi-year logistics transformation with a stated long-term savings target, planned synthetic-dye changes, and new line- and process-level visibility tools associated with efficiency gains.
Guidance delta
Management maintained FY2025 guidance after the prior quarter's increase: sales flat to +1%, adjusted operating income $1.9-$2.3 billion, capital expenditures $1-$1.2 billion, and free cash flow $1-$1.6 billion.
Key takeaways
- The supplied analysis describes a fourth consecutive quarter of year-over-year growth in sales, adjusted operating income, and EPS.
- Chicken delivered its best Q2 operating income in nine years, with double-digit volume growth.
- Prepared Foods margins improved, while management highlighted product innovation and operational efficiency.
- The company maintained its full-year outlook rather than raising it again.
- A logistics transformation is intended to improve the cold-storage network and support long-term savings.
Management priorities
- Execute the multi-year logistics transformation and cold-storage network changes.
- Invest about $100 million in chicken operations during the second half of FY2025.
- Continue product launches across chicken, pork, beef, and prepared foods.
- Use diversified pricing strategies to manage input-cost and market volatility.
- Complete the planned elimination of petroleum-based synthetic dyes from specified products.
Follow TSN with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$53.79Previous close
$35Low
$62.9Average
$99High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Piper Sandler | Overweight | Overweight | Maintain | Oct 7, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | Sep 18, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Sep 4, 2026 |
| Barclays | Overweight | Overweight | Maintain | Sep 4, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Jul 2, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 2, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | May 5, 2026 |
| Mizuho | Outperform | Buy | Maintain | Mar 26, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Apr 15, 2025 |
| HSBC | Reduce | Reduce | Maintain | May 7, 2024 |
| Goldman Sachs | Neutral | Neutral | Maintain | Apr 17, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Feb 7, 2023 |
| Argus Research | Hold | Buy | Downgrade | Sep 13, 2022 |
| Buckingham Research | Neutral | Neutral | Maintain | Feb 20, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Feb 20, 2020 |
| Bank of America | Buy | Buy | Maintain | Nov 13, 2019 |
| Argus | Buy | Hold | Upgrade | May 14, 2019 |
| Vertical Research | Buy | Hold | Upgrade | Jan 10, 2019 |
| Vertical Group | Buy | Hold | Upgrade | Jan 10, 2019 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 8, 2018 |
| Pivotal Research | Hold | Sell | Upgrade | Nov 13, 2017 |
| Jefferies | Buy | Buy | Maintain | Oct 30, 2017 |
| CLSA | Buy | Outperform | Maintain | Oct 10, 2016 |
| BB&T Capital | Hold | Buy | Downgrade | Mar 4, 2016 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Jan 5, 2016 |
| Cleveland Research | Buy | Neutral | Upgrade | Feb 5, 2015 |
| KeyBanc | Buy | Buy | Maintain | Jul 29, 2014 |
| DA Davidson | Buy | Buy | Maintain | Jul 10, 2013 |
| Miller Tabak | Buy | Neutral | Upgrade | May 7, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $53.79. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $56 | $51.97 | +4.1% | Oct 7, 2026 |
| Piper Sandler | Analyst unavailable | $66 | $51.74 | +22.7% | Sep 10, 2026 |
| Barclays | Analyst unavailable | $75 | $51.76 | +39.4% | Sep 4, 2026 |
| BMO Capital | Andrew Strelzik | $65 | $51.76 | +20.8% | Sep 4, 2026 |
| Bernstein | Alexia Howard | $66 | $58.12 | +22.7% | Aug 4, 2026 |
| Coker Palmer | Thomas Palmer | $65 | $57.48 | +20.8% | Jul 14, 2026 |
| Bernstein | Analyst unavailable | $63 | $58.43 | +17.1% | Jul 2, 2026 |
| Piper Sandler | Michael Lavery | $78 | $56.2 | +45.0% | Jun 18, 2026 |
| Piper Sandler | Analyst unavailable | $80 | $68.76 | +48.7% | May 4, 2026 |
| Bernstein | Analyst unavailable | $69 | $65.74 | +28.3% | Feb 3, 2026 |
| BMO Capital | Andrew Strelzik | $73 | $65.74 | +35.7% | Feb 3, 2026 |
| Barclays | Analyst unavailable | $78 | $65.74 | +45.0% | Feb 3, 2026 |
| BMO Capital | Analyst unavailable | $67 | $56.2 | +24.6% | Jan 8, 2026 |
| Piper Sandler | Michael Lavery | $61 | $59.56 | +13.4% | Dec 12, 2025 |
| Stephens | Pooran Sharma | $61 | $55.75 | +13.4% | May 6, 2025 |
| Coker Palmer | Thomas Palmer | $60 | $60.54 | +11.5% | Apr 15, 2025 |
| Piper Sandler | Michael Lavery | $58 | $61.69 | +7.8% | Nov 13, 2024 |
| BMO Capital | Andrew Strelzik | $62 | $61.69 | +15.3% | Nov 13, 2024 |
| Barclays | Benjamin Theuer | $76 | $62.66 | +41.3% | Nov 12, 2024 |
| Bank of America Securities | Peter Galbo | $62 | $59.85 | +15.3% | Oct 15, 2024 |
| Piper Sandler | Michael Lavery | $50 | $60.52 | -7.0% | Sep 25, 2024 |
| Barclays | Benjamin Theuer | $72 | $65.13 | +33.9% | Sep 5, 2024 |
| BMO Capital | Andrew Strelzik | $60 | $62.08 | +11.5% | Aug 6, 2024 |
| Coker Palmer | Thomas Palmer | $63 | $62.51 | +17.1% | Aug 5, 2024 |
| Piper Sandler | Michael Lavery | $57 | $58.33 | +6.0% | May 7, 2024 |
| BMO Capital | Andrew Strelzik | $58 | $58.28 | +7.8% | May 7, 2024 |
| Barclays | Benjamin Theuer | $69 | $58.12 | +28.3% | Apr 16, 2024 |
| Coker Palmer | Thomas Palmer | $62 | $57.6 | +15.3% | Apr 3, 2024 |
| Loop Capital Markets | Andrew Strelzik | $46 | $47.77 | -14.5% | Nov 14, 2023 |
| Stephens | Ben Bienvenu | $70 | $47.58 | +30.1% | Nov 14, 2023 |
| Barclays | Benjamin Theurer | $50 | $46.39 | -7.0% | Nov 10, 2023 |
| UBS | Kevin Caliendo | $37 | $52.66 | -31.2% | Jul 24, 2023 |
| Deutsche Bank | Steve Powers | $35 | $50.39 | -34.9% | May 19, 2023 |
| Bernstein | Alexia Howard | $48 | $48.95 | -10.8% | May 9, 2023 |
| J.P. Morgan | Analyst unavailable | $63 | $59.92 | +17.1% | Feb 7, 2023 |
| Credit Suisse | Analyst unavailable | $58 | $61.08 | +7.8% | Feb 7, 2023 |
| Goldman Sachs | Analyst unavailable | $66 | $61.08 | +22.7% | Feb 7, 2023 |
| Piper Sandler | Analyst unavailable | $65 | $65.75 | +20.8% | Feb 1, 2023 |
| Barclays | Analyst unavailable | $58 | $67.33 | +7.8% | Nov 28, 2022 |
| J.P. Morgan | Analyst unavailable | $70 | $64.34 | +30.1% | Nov 15, 2022 |
| BMO Capital | Analyst unavailable | $75 | $64.83 | +39.4% | Nov 15, 2022 |
| Piper Sandler | Michael Lavery | $79 | $79.92 | +46.9% | Aug 9, 2022 |
| Piper Sandler | Michael Lavery | $85 | $92.84 | +58.0% | May 10, 2022 |
| Piper Sandler | Michael Lavery | $81 | $90.1 | +50.6% | May 3, 2022 |
| BMO Capital | Kenneth Zaslow | $99 | $87.14 | +84.0% | Mar 18, 2022 |
Track every rating change on TSN the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationTyson Foods, Inc. operates as a prominent global food producer, encompassing a broad range of activities across four core divisions: Beef, Pork, Chicken, and Prepared Foods. Within its Beef and Pork segments, the company manages the entire process from live cattle and hogs to their transformation into various meat products. This includes fabricating whole carcasses into primary and secondary cuts, providing case-ready options, and producing fully cooked meats. Its Chicken division is responsible for raising and processing poultry, delivering a spectrum of fresh, frozen, and value-added chicken items, and also supplying breeding stock. Additionally, Tyson markets specialty by-products such as animal hides. The Prepared Foods unit focuses on manufacturing and distributing a diverse portfolio of frozen and refrigerated convenience foods.…
Historical context
All TSN earningsConsumer Defensive peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| PEP PepsiCo, Inc. | FY2026 Q3 · Calendar Q4 2026 | +2.2% | +3.7% | PepsiCo: International Growth Offsets U.S. Soft-Drink and Margin Pressure |
| STZ Constellation Brands, Inc. | FY2027 Q2 · Calendar Q4 2026 | +5.4% | +2.4% | Constellation Brands beats expectations and maintains FY27 EPS guidance |
| LW Lamb Weston Holdings, Inc. | FY2027 Q1 · Calendar Q4 2026 | +27.8% | +7.5% | Lamb Weston raises FY2027 outlook as North America volume growth continues |
| MKC McCormick & Company, Incorporated | FY2026 Q3 · Calendar Q4 2026 | +13.9% | -4.9% | McCormick reports strong Q3 growth while U.S. volumes remain soft |
| CAG Conagra Brands, Inc. | FY2027 Q1 · Calendar Q3 2026 | +44.4% | -4.9% | Conagra maintains outlook while increasing brand investment and simplifying SKUs |
| COST Costco Wholesale Corporation | FY2026 Q4 · Calendar Q3 2026 | +3.2% | +2.9% | Costco’s growth broadens as warehouses and digital sales accelerate |
Latest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the TSN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-04-21T00:03:31.337707+00:00
- Polygon adjusted daily market bars · 2026-10-14T06:00:44.523300+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-14T06:00:44.520494+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-14. For educational purposes only; not investment advice.